Peter Würtz to give two talks at AHA2016

Photo credit Nightingale Health

Our Scientific Director Dr. Peter Würtz will present two studies utilizing our technology at American Heart Association's Scientific Sessions – AHA 2016. The event features the best in science and cardiovascular clinical practice and will be held in New Orleans, November 12-16.

The presentations

Metabolomic Effects of Statin Therapy, Ezetimibe and PCSK9-Inhibition: Comparison by Genetic Evidence, Nov 15, 12:30PM
Link to study

Metabolomics of Non-alcoholic Fatty Liver Disease in Young Adults Reveals Pronounced Metabolic Deviations Prior to Disease Onset, Nov 15, 4:30PM

To set up a meeting with us at AHA Scientific Sessions, please send an email to contact[at]